Yudhveer Brar, MD
Internal Medicine · Colusa
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
- Since medical school
- 7 years
- Graduated 2019
Offices
2 locations · American Specialty Physicians Group Inc · Arya Medical Group Corp
Hospitals listed: Memorial Hospital Los Banos. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Brar’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A183813 · Current
Licensed to practise in California · since 2023 · expires 2027-04-30 · American University of Antigua College of Medicine (Antigua Campus).
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Internal Medicine
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Memorial Hospital Los BanosLos Banos, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 59% would definitely recommend itOverall rating: 3 of 5 starsNo measure marked better or worse than the national rate
See every measure and the patient survey for Memorial Hospital Los Banos
Behind the star rating — Deaths: 0 better, 4 the same, 0 worse of 4 measures. Safety: 0 better, 2 the same, 0 worse of 2 measures. Readmissions: 0 better, 3 the same, 0 worse of 3 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.04 (0 to 2.13) · 48 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.94 (0.46 to 1.43) | No different | Jul 2022 – Jun 2024 |
| Death rate for heart failure patientsComplications and deaths | 14.5 · 47 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.4 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.5 · 33 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.6 · 324 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.21 (0 to 0.44) · 797 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.05 to 0.48) · 753 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.36 (0.77 to 5.95) · 105 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.31 (0.58 to 4.03) · 100 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.76 (0.23 to 3.29) · 31 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.49 (0 to 1.69) · 573 cases | No different | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.9 · 56 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 20.3 · 47 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 34.5 · 80 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18 · 86 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.5 (9.8 to 18.5) · 59 cases | No different | Jan 2022 – Dec 2024 |
What patients said (172 patients answered, 12% of those asked)
| Cleanliness | 5 |
| Nurse communication | 4 |
| Doctor communication | 2 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 81% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 64% |
| Yes, staff "did" give patients this information | 80% |
| Yes, staff "did" give patients information about help after discharge | 75% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 81% |
| Patients who gave a rating of "9" or "10" (high) | 71% |
| Staff "always" explained new medications | 82% |
| Nurses "always" explained things so they could understand | 78% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 48% |
| "YES", patients would definitely recommend the hospital | 59% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$7,184
Medicare paid this office $7,184 for 51 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 32 | $4,461 | $135 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 13 | $1,829 | $91 |
Who their Medicare patients are
51 Original Medicare patients in 2024. Average age 74 · Women 57% · Also on Medicaid 65% · Health risk score 2.70. Above the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 75% · Diabetes 59% · Coronary heart disease 49% · Chronic kidney disease 49% · Heart failure 47% · Depression 35% · COPD 31% · Atrial fibrillation 27% · Dementia 24%.
The office billed $27,962, Medicare allowed $9,016 and paid $7,184; for 63 services of 3 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 51 | 63 | 74 | 2.70 | $27,962 | $7,184 |
| 2023 | 28 | 37 | 80 | 2.23 | $14,906 | $4,109 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 2 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 16 | $1,991 | $95 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 14 | $1,935 | $138 |
Medicaid work
$876,260 in 2024
Medicaid paid $876,260 for 65,834 billed services this clinician did in 2024, up to 436 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 5,535 | $872,898 |
| Screening performed and negative | 335 | $1,682 |
| 1ST HOSP IP/OBS HIGH 75 | 13 | $801 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 23 | $632 |
| Short return visit (20+ min) | 7,302 | $246 |
| Current tobacco smoker (CAD, CAP, COPD, PV) (DM) | 1,340 | $0 |
| Current smokeless tobacco user (eg, chew, snuff) (PV) | 95 | $0 |
| TOBACCO NON-USER | 8,044 | $0 |
| Pain severity quantified; pain present (COA) (ONC) | 1,068 | $0 |
| Pain severity quantified; no pain present (COA) (ONC) | 5,672 | $0 |
| Medication list documented in medical record (COA) | 1,654 | $0 |
| Review of all medications by a prescribing practitioner or clinical pharmacist (such as, prescriptions, OTCs, herbal therapies and supplements) documented in the medical record (COA) | 1,654 | $0 |
| 2024 | 65,834 | 36 | 436 | $876,260 |
| 2023 | 18,016 | 26 | 216 | $233,052 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 1,493 | $232,275 |
| Screening performed and negative | 116 | $609 |
| Short return visit (20+ min) | 1,619 | $168 |
| SARSCOV CORONAVIRUS AG IA | 89 | $0 |
| Current tobacco smoker (CAD, CAP, COPD, PV) (DM) | 320 | $0 |
| Current smokeless tobacco user (eg, chew, snuff) (PV) | 39 | $0 |
| TOBACCO NON-USER | 1,741 | $0 |
| Pain severity quantified; pain present (COA) (ONC) | 390 | $0 |
| Pain severity quantified; no pain present (COA) (ONC) | 968 | $0 |
| Medication list documented in medical record (COA) | 2,175 | $0 |
| Review of all medications by a prescribing practitioner or clinical pharmacist (such as, prescriptions, OTCs, herbal therapies and supplements) documented in the medical record (COA) | 2,176 | $0 |
| BODY MASS INDEX DOCD | 1,425 | $0 |
Drugs they prescribed that Part D paid
$384,562
Pharmacies billed $384,562 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
2,158 generic and 510 brand-name prescriptions · $384,562 in drug cost · 102 antibiotic prescriptions to 66 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Jardiance | 101 | $89,857 | $890 |
| Ozempic | 79 | $79,841 | $1,011 |
| Januvia | 26 | $24,159 | $929 |
| Trulicity | 21 | $18,397 | $876 |
| Eliquis | 16 | $14,283 | $893 |
See all 58 drugs
| Jardiance | 101 | $89,857 | $890 |
| Ozempic | 79 | $79,841 | $1,011 |
| Januvia | 26 | $24,159 | $929 |
| Trulicity | 21 | $18,397 | $876 |
| Eliquis | 16 | $14,283 | $893 |
| Farxiga | 14 | $13,459 | $961 |
| Linzess | 15 | $10,543 | $703 |
| Trelegy Ellipta | 14 | $9,928 | $709 |
| Levothyroxine | 61 | $1,590 | $26 |
| Lantus Solostar | 14 | $1,532 | $109 |
| Albuterol Sulfate Hfa | 64 | $1,443 | $23 |
| Atorvastatin | 163 | $1,396 | $9 |
| Gabapentin | 127 | $1,121 | $9 |
| Celecoxib | 32 | $1,020 | $32 |
| Metoprolol | 62 | $881 | $14 |
| Nifedipine Er | 13 | $858 | $66 |
| Rosuvastatin | 24 | $549 | $23 |
| Diclofenac | 25 | $539 | $22 |
| Amlodipine Besylate-Benazepril | 54 | $534 | $10 |
| Fenofibrate | 15 | $502 | $33 |
| Amlodipine Besylate | 107 | $497 | $5 |
| Tamsulosin | 38 | $491 | $13 |
| Metformin | 66 | $415 | $6 |
| Omeprazole | 46 | $405 | $9 |
| Lisinopril | 89 | $355 | $4 |
| Losartan | 49 | $301 | $6 |
| Losartan-Hydrochlorothiazide | 22 | $261 | $12 |
| Fluticasone Propionate | 36 | $260 | $7 |
| Pantoprazole | 23 | $238 | $10 |
| Oxybutynin Chloride Er | 15 | $228 | $15 |
| Trazodone | 45 | $220 | $5 |
| Nitrofurantoin Mono-Macro | 27 | $216 | $8 |
| Pioglitazone | 15 | $197 | $13 |
| Escitalopram | 44 | $194 | $4 |
| Montelukast | 31 | $185 | $6 |
| Pravastatin | 14 | $175 | $12 |
| Triamcinolone Acetonide | 11 | $153 | $14 |
| Furosemide | 45 | $142 | $3 |
| Glipizide | 30 | $140 | $5 |
| Cyclobenzaprine | 36 | $135 | $4 |
| Hydrochlorothiazide | 46 | $133 | $3 |
| Simvastatin | 28 | $128 | $5 |
| Vitamin D2 | 20 | $126 | $6 |
| Metformin Hcl Er | 29 | $126 | $4 |
| Finasteride | 18 | $126 | $7 |
| Famotidine | 16 | $118 | $7 |
| Amoxicillin-Clavulanate Potass | 19 | $100 | $5 |
| Meloxicam | 25 | $100 | $4 |
| Amitriptyline | 13 | $83 | $6 |
| Hydroxyzine | 15 | $83 | $6 |
| Ibuprofen | 38 | $83 | $2 |
| Methylprednisolone | 13 | $77 | $6 |
| Alendronate | 17 | $73 | $4 |
| Carvedilol | 15 | $66 | $4 |
| Tizanidine | 18 | $65 | $4 |
| Prednisone | 19 | $56 | $3 |
| Azithromycin | 13 | $24 | $2 |
| Donepezil | 12 | $17 | $1 |
Year by year
| 2024 | 2,693 | 276 | None | 19% | $384,562 |
| 2023 | 345 | 72 | None | None | $36,508 |
| 2022 | 71 | 25 | 0% (0) | 18% | $9,005 |
| 2021 | 96 | 20 | 0% (0) | 18% | $10,962 |
| 2020 | 16 | None | 0% (0) | None | $432 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 5 drugs
| Atorvastatin | 18 | $462 | $26 |
| Amlodipine Besylate | 19 | $199 | $10 |
| Lisinopril | 12 | $184 | $15 |
| Gabapentin | 14 | $115 | $8 |
| Furosemide | 15 | $51 | $3 |
Money from drug and device companies
$24 in 2024
| 2024 | 1 | 1 | None | $24 |
| 2023 | 2 | 2 | None | $35 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Mavyret | $24 | 1 payment
|
See the published payment
| Abbvie | Meals · 2024-11-21 | Mavyret | $24 |
See earlier years (2023)
2023: $35
| Daiichi Sankyo | Injectafer | $18 | 1 payment
|
| Alkermes | Vivitrol | $17 | 1 payment
|
Professional record
- NPI
- 1568081750
- Licence
- CA A183813California A183813: Current · expires 2027-04-30
- Group
- American Specialty Physicians Group Inc · Arya Medical Group Corp
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 1313 E Herndon Ave, Fresno, CA, 93720
- NPI first listed
- 2020-04-09
- NPI last updated
- 2023-06-15
- NPI record certified
- 2023-06-15
This is when the NPI record was last certified, not a medical board exam.